advertising
-
1
Cundy TF, Edmonds ME, Watkins PJ: Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med 2: 461, 1985.
-
2
Ferrari SL, Abrahamsen B, Napoli N, et al: Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29: 2585, 2018.
-
3
Leslie WD, Aubry-Rozier B, Lamy O, et al: TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab 98: 602, 2013.
-
4
Chen FP, Kuo SF, Lin YC, et al: Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes. Menopause 26: 182, 2019.
-
5
Gutekunst DJ, Smith KE, Commean PK, et al: Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices. Bone 51: 407, 2013.
-
6
Wukich DK, Joseph A, Ryan M, et al: Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle Int 32: 120, 2011.
-
7
Frykberg RG, Belczyk R: Epidemiology of the Charcot foot. Clin Podiatr Med Surg 25: 17, 2008.
-
8
Hartemann-Heutier A, Van GH, Grimaldi A: The Charcot foot. Lancet 360: 1776, 2002.
-
9
Sohn MW, Stuck RM, Pinzur M, et al: Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes Care 33: 98, 2010.
-
10
Jeffcoate W: Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev 24: 62, 2008.
-
11
Foltz KD, Fallat LM, Schwartz S: Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg 43: 87, 2004.
-
12
Sinha S, Munichoodapa CS, Kozak GP: Neuroarthropathy (Charcot joints) in diabetes mellitus. Medicine 51: 191, 1972.
-
13
Khan SA, Kurwa HA, Prentice MG: Atraumatic fractures in Type 1 diabetes. Diabet Med 12: 179, 1995.
-
14
El-Khoury GY, Katho MH: Neuropathic fractures in patients with diabetes mellitus. Radiology 134: 313, 1980.
-
15
Lavery LA, Lavery DC, Green T, et al: Increased risk of nonunion and Charcot arthropathy after ankle fracture in people with diabetes. J Foot Ankle Surg 59: 653, 2020.
-
16
Kristiansen B: Ankle and foot fractures in diabetics provoking neuropathic joint changes. Acta Orthop Scand 51: 975, 1980.
-
17
Low CK, Tan SK: Infection in diabetic patients with ankle fractures. Ann Acad Med Singapore 24: 353, 1995.
-
18
Connolly JF, Csencsitz TA: Limb threatening neuropathic complications from ankle fractures in patients with diabetes. Clin Orthop Relat Res 384: 212, 1998.
-
19
Holmes GB, Hill N: Fractures and dislocations of the foot and ankle in diabetics associated with Charcot joint changes. Foot Ankle Int 15: 182, 1994.
-
20
Schon LC, Marks RM: The management of neuropathic fracture dislocation in the diabetic patient. Orthop Clin North Am 26: 375,1995.
-
21
Costigan WB, Thordarson DB: Surgical management of ankle fractures in diabetics. Paper presented at: Thirteenth Annual Summer Meeting of the American Orthopaedic Foot and Ankle Society; Monterey, CA; July 17-19, 1997.
-
22
Blotter RH, Connolly E, Wasan A, et al: Acute complications in the operative treatment of isolated ankle fractures in patients with diabetes mellitus. Foot Ankle Int 20: 687,1999.
-
23
Bibbo C, Lin SS, Beam HA, et al: Complications of ankle fractures in diabetic patients. Orthop Clin North Am 32: 113, 2001.
-
24
Lillmars SA, Meister BA: Acute trauma to the diabetic foot and ankle. Curr Opin Orthop 12: 100, 2001.
-
25
Akkawi I, Zmerly H: Osteoporosis: current concepts. Joints 6: 122, 2018.
-
26
WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. World Health Organ Tech Rep Ser 843: 1, 1994.
-
27
Jirkovska A, Kasalicky P, Boucek P, et al: Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med 18: 495, 2001.
-
28
Herbst SA, Jones KB, Saltzman CL: Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 86: 378, 2004.
-
29
Chirvi S, Pintar FA, Yoganandan N, et al: Trabecular bone mineral density correlations using QCT: central and peripheral human skeleton. J Mech Behav Biomed Mater 112: 104076, 2020.
-
30
Ergen FB, Sanverdi SE, Oznur A: Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle 20: 4, 2013.
-
31
Wright NC Looker AC, Saag KG, et al: The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29: 2520, 2014.
-
32
Carlson BB, Salzmann SN, Shirahata T, et al: Prevalence of osteoporosis and osteopenia diagnosed using quantitative CT in 296 consecutive lumbar fusion patients. Neurosurg Focus 49: E5, 2020.
-
33
Rogers LC, Bevilacqua NJ: The diagnosis of Charcot foot. Clin Podiatr Med Surg 25: 43, 2008.
-
34
Sinacore DR: Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot ulceration. J Diabetes Complications 12: 287, 1998.
-
35
So E, Rushing CJ, Simon JE, et al: Association between bone mineral density and elderly ankle fractures: a systematic review and meta-analysis. J Foot Ankle Surg 59: 1049, 2020.
-
36
Stein EM, Liu XS, Nickolas TL, et al: Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab 96: 2041, 2011.
-
37
Hastings MK, Sinacore DR, Fielder FA, et al: Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther 85: 249, 2005.
-
38
Sinacore DR, Hastings MK, Bohnert KL, et al: Immobilization-induced osteolysis and recovery in neuropathic foot impairments. Bone 105: 237, 2017.
-
39
Greenhagen RM, Wukich DK, Jung RH, et al: Peripheral and central bone mineral density in Charcot's neuroarthropathy compared in diabetic and nondiabetic populations. JAPMA 102: 213, 2012.
-
40
Durgia H, Sahoo J, Kamalanathan S, et al: Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes 9: 115, 2018.
Association of Anatomical Location of Neuroarthropathic (Charcot’s) Destruction with Age-and Sex-Matched Bone Mineral Density Reduction
Search for other papers by Craig J. Verdin in
Current site
Google Scholar
PubMed
Search for other papers by Georgeanne G. Botek in
Current site
Google Scholar
PubMed
Search for other papers by John David Miller in
Current site
Google Scholar
PubMed
Search for other papers by James D. Kingsley in
Current site
Google Scholar
PubMed
Search for other papers by Danny Plyler in
Current site
Google Scholar
PubMed
Background: It is well documented that diabetes has a systemic impact on bone mineral density. Recent literature has evaluated the relationship between the development of Charcot neuroarthropathy and reduced local bone mineral density; however, it is not clear if there is an association between osteoporosis/osteopenia and Charcot onset, or, even further, location of neuroarthropathic breakdown.
Methods: We retrospectively identified and assessed 39 patients with 41 feet (4 bilateral) with a history of Charcot breakdown who underwent a bone mineral density scan over a 15-year period. Demographic, radiographic, and bone mineral density information was analyzed.
Results: The average patient age at the time of bone mineral density scan was 53.44 ± 8.09 years, and 52.77 ± 8.19 years at the time of Charcot diagnosis. Four feet were considered Sanders-Frykberg I (9.3%), 17 were Sanders-Frykberg II (39.5%), ten were Sanders-Frykberg III (23.3%), and 12 were Sanders-Frkyberg IV/V (27.9%). Neuroarthropathic breakdown of the rearfoot region (Sanders-Frykberg IV/V) was found to be associated and preceded by osteoporosis and osteopenia at the hip as demonstrated by a lower Z-score (P = 0.05). Charcot neuroarthropathy was not associated with poor bone health or loss of bone mineral density at the femoral neck, forearm, or lumbar spine.
Conclusions: We believe that the present findings suggest a possible relationship between osteoporosis/osteopenia and the location of CN development. With these findings in mind, we conclude that patients with diabetic skeletal fragility may benefit from treatment of underlying poor bone mineral density to prevent the onset of Charcot neuroarthropathy.
advertising
